Z Gastroenterol 2024; 62(01): e16-e17
DOI: 10.1055/s-0043-1777510
Abstracts | GASL
Poster Visit Session ll CLINICAL HEPATOLOGY, SURGERY, LTX 26/01/2024, 14.20pm–15.15pm

The Freiburg Index of Post-TIPS Survival (FIPS) identifies patients with further decompensation after transjugular intrahepatic portosystemic shunt implantation: a multicenter observational study

Lukas Sturm
1   Medical Center University of Freiburg
,
Michael Schultheiß
1   Medical Center University of Freiburg
,
Fabian Stoehr
2   University Medical Center of the Johannes Gutenberg-University Mainz
,
Christian Labenz
2   University Medical Center of the Johannes Gutenberg-University Mainz
,
Anja Tiede
3   Hannover Medical School
,
Benjamin Maasoumy
3   Hannover Medical School
,
Michael Praktiknjo
4   University Hospital Münster
,
Leon Louis Seifert
4   University Hospital Münster
,
Timo Alexander Auer
5   Charité University Hospital Berlin, Germany
,
Uli Fehrenbach
5   Charité University Hospital Berlin, Germany
,
Felix Piecha
6   University Medical Center Hamburg-Eppendorf
,
Johannes Kluwe
6   University Medical Center Hamburg-Eppendorf
,
Johannes Chang
7   University Hospital Bonn (UKB)
,
Christian Jansen
7   University Hospital Bonn (UKB)
,
Maike Rebecca Pollmanns
8   University Hospital Aachen
,
Tony Bruns
8   University Hospital Aachen
,
Carsten Meyer
7   University Hospital Bonn (UKB)
,
Marlene Reincke
1   Medical Center University of Freiburg
,
Jan B. Hinrichs
9   St. Bernward Krankenhaus Hildesheim
,
Michael Köhler
4   University Hospital Münster
,
Jonel Trebicka
4   University Hospital Münster
,
Roman Klockner
10   University Hospital Schleswig-Holstein, Campus Lübeck
,
Robert Thimme
1   Medical Center University of Freiburg
,
Dominik Bettinger
1   Medical Center University of Freiburg
› Institutsangaben
 
 

    Introduction The Freiburg Index of Post-TIPS Survival (FIPS) defines a high-risk group of patients with significantly impaired survival following TIPS implantation. As further decompensation is significantly associated with reduced survival, we hypothesized that further decompensation may be an important hallmark in FIPS high-risk patients after TIPS.

    Methods 1514 cirrhosis patients allocated to TIPS implantation for treatment of refractory ascites or secondary prophylaxis of variceal bleeding from eight centers were retrospectively included. Primary outcome was further decompensation within 90 days after TIPS. Secondary outcomes were the development of acute-on-chronic liver failure (ACLF) within 90 days and one-year transplant-free survival.

    Results The cumulative incidence of further decompensation, with death and liver transplantation as competing risks, was significantly higher in FIPS high-risk patients compared to low-risk patients (0.56 vs. 0.36). Moreover, the cumulative incidence of ACLF within 90 days after TIPS was markedly increased in high-risk patients (0.37 vs. 0.11). Uni- and multivariable competing risk-regression analyses confirmed that FIPS high-risk classification was an independent predictor of further decompensation (SHR 1.768, 95% CI 1.454 – 2.149, p<0.001) and ACLF after TIPS (SHR 1.943, 95% CI 1.276 – 2.958, p=0.002). Further decompensation and the development of ACLF after TIPS were associated with significantly reduced transplant-free survival.

    Conclusions The present study reveals that the FIPS predicts further decompensation after TIPS implantation, which might explain impaired survival in FIPS high-risk patients. Therefore, tailored clinical management strategies including early evaluation for liver transplantation for FIPS high-risk patients should be considered.


    #

    Publikationsverlauf

    Artikel online veröffentlicht:
    23. Januar 2024

    © 2024. Thieme. All rights reserved.

    Georg Thieme Verlag
    Rüdigerstraße 14, 70469 Stuttgart, Germany